Homology model-assisted elucidation of binding sites in GPCRs

Methods in Molecular Biology

Volumn 914, Issue , 2012, Pages 179-205

  Levit, Anat ^a   Barak, Dov ^b   Behrens, Maik ^c   Meyerhof, Wolfgang ^c   Niv, Masha Y ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

^c GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

Author keywords

Agonist; Antagonist; Binding site; Broad tuning; Docking; GPCR model; Molecular recognition; Receptor range; Taste receptors

Indexed keywords

ARISTOLOCHIC ACID; G PROTEIN COUPLED RECEPTOR; LIGAND; OLIGONUCLEOTIDE; STRYCHNINE;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; COMPUTER; DATA BASE; HUMAN; HUMAN CELL; LIGAND BINDING; MUTAGENESIS; PRIORITY JOURNAL; QUALITY CONTROL; RECEPTOR BINDING; SEQUENCE HOMOLOGY; TASTE BUD;

EID: 84865201339     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-23-6_11     Document Type: Article

References (88)

1. Heilker R et al (2009) G-protein-coupled receptor-focused drug discovery using a target class platform approach. Drug Discov Today 14:231-240
2. Rosenbaum DM, Rasmussen SGF, Kobilka BK (2009) The structure and function of G-protein-coupled receptors. Nature 459: 356-363
3. Topiol S, Sabio M (2009) X-ray structure breakthroughs in the GPCR transmembrane region. Biochem Pharmacol 78:11-20
4. Sprang SR (2011) Cell signalling: binding the receptor at both ends. Nature 469:172-173
5. Xu F et al (2011) Structure of an agonistbound human A2A adenosine receptor. Science 332(6027):322-327
6. Mobarec JC, Sanchez R, Filizola M (2009) Modern homology modeling of G-protein coupled receptors: which structural template to use? J Med Chem 52:5207-5216
7. Yarnitzky T, Levit A, Niv MY (2010) Homology modeling of G-protein-coupled receptors with X-ray structures on the rise. Curr Opin Drug Discov Devel 13:317-325
8. Senderowitz H, Marantz Y (2009) G Proteincoupled receptors: target-based in silico screening. Curr Pharm Des 15:4049-4068
9. de Graaf C, Rognan D (2009) Customizing G Protein-coupled receptor models for structurebased virtual screening. Curr Pharm Des 15: 4026-4048
10. Reisert J, Restrepo D (2009) Molecular tuning of odorant receptors and its implication for odor signal processing. Chem Senses 34: 535-545
11. Cui M et al (2006) The heterodimeric sweet taste receptor has multiple potential ligand binding sites. Curr Pharm Des 12:4591-4600
12. Brockhoff A et al (2010) Structural requirements of bitter taste receptor activation. Proc Natl Acad Sci U S A 107:11110-11115
13. Lagerstrom MC, Schioth HB (2008) Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 7:339-357
14. Harmar AJ et al (2009) IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels. Nucleic Acids Res 37:D680-D685
15. Petrel C et al (2004) Positive and negative allosteric modulators of the Ca 2+ -sensing receptor interact within overlapping but not identical binding sites in the transmembrane domain. J Biol Chem 279:18990-18997
16. Bhattacharya S et al (2010) Allosteric antagonist binding sites in class B GPCRs: corticotropin receptor 1. J Comput Aided Mol Des 24:659-674
17. Niv MY et al (2006) Modeling activated states of GPCRs: the rhodopsin template. J Comput Aided Mol Des 20:437-448
18. Niv MY, Filizola M (2008) In fluence of oligomerization on the dynamics of G-proteincoupled receptors as assessed by normal mode analysis. Proteins 71:575-586
19. Ivanov AA, Barak D, Jacobson KA (2009) Evaluation of homology modeling of G-proteincoupled receptors in light of the A(2A) adenosine receptor crystallographic structure. J Med Chem 52:3284-3292
20. Slack JP et al (2010) Modulation of bitter taste perception by a small molecule hTAS2R antagonist. Curr Biol 20:1104-1109
21. Biarnes X et al (2010) Insights into the binding of phenyltiocarbamide (PTC) agonist to its target human TAS2R38 bitter receptor. PLoS One 5:e12394
22. Vaidehi N, Pease JE, Horuk R (2009) Modeling small molecule-compound binding to G-protein-coupled receptors. Methods Enzymol 460:263-288
23. Simms J et al (2009) Homology modeling of GPCRs. Methods Mol Biol 552:97-113
24. Zhang Y (2009) I-TASSER: fully automated protein structure prediction in CASP8. Proteins 77(Suppl 9):100-113
25. Ballesteros JA, Weinstein H (1995) Integrated methods for the construction of three dimensional models and computational probing of structure function relations in G proteincoupled receptors. Methods Neurosci 25: 366-428
26. Okuno Y et al (2008) GLIDA: GPCR ligand database for chemical genomics drug discovery database and tools update. Nucleic Acids Res 36:D907-D912
27. Ivetac A, McCammon JA (2010) Mapping the druggable allosteric space of G-protein-coupled receptors: a fragment-based molecular dynamics approach. Chem Biol Drug Des 76:201-217
28. Beukers MW et al (1999) TinyGRAP database: a bioinformatics tool to mine G-proteincoupled receptor mutant data. Trends Pharmacol Sci 20:475-477
29. Horn F, Lau AL, Cohen FE (2004) Automated extraction of mutation data from the literature: application of MuteXt to G protein-coupled receptors and nuclear hormone receptors. Bioinformatics 20:557-568
30. Costanzi S (2008) On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor. J Med Chem 51:2907-2914
31. Reynolds KA, Katritch V, Abagyan R (2009) Identifying conformational changes of the beta(2) adrenoceptor that enable accurate prediction of ligand/receptor interactions and screening for GPCR modulators. J Comput Aided Mol Des 23:273-288
32. Laurie AT, Jackson RM (2005) Q-SiteFinder: an energy-based method for the prediction of protein-ligand binding sites. Bioinformatics 21:1908-1916
33. Cherezov V et al (2007) High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318:1258-1265
34. Hanson MA et al (2008) A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. Structure 16:897-905
35. Floriano WB et al (2006) Modeling the human PTC bitter-taste receptor interactions with bitter tastants. J Mol Model 12:931-941
36. Miguet L, Zhang Z, Grigorov MG (2006) Computational studies of ligand-receptor interactions in bitter taste receptors. J Recept Signal Transduct Res 26:611-630
37. Rasmussen SG et al (2011) Structure of a nanobody-stabilized active state of the beta(2) adrenoceptor. Nature 469:175-180
38. Horn F et al (2003) GPCRDB information system for G protein-coupled receptors. Nucleic Acids Res 31:294-297
39. Jones G et al (1997) Development and validation of a genetic algorithm for flexible docking. J Mol Biol 267:727-748
40. Friesner RA et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739-1749
41. Halgren TA et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J Med Chem 47:1750-1759
42. Venkatachalam CM et al (2003) LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. J Mol Graph Model 21:289-307
43. Wu G et al (2003) Detailed analysis of gridbased molecular docking: a case study of CDOCKER-A CHARMm-based MD docking algorithm. J Comput Chem 24:1549-1562
44. Wallace AC, Laskowski RA, Thornton JM (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng 8:127-134
45. Fang G et al (1999) PCR-mediated recombination: a general method applied to construct chimeric infectious molecular clones of plasmaderived HIV-1 RNA. Nat Med 5:239-242
46. Reichling C, Meyerhof W, Behrens M (2008) Functions of human bitter taste receptors depend on N-glycosylation. J Neurochem 106:1138-1148
47. Behrens M et al (2004) Molecular cloning and characterisation of DESC4, a new transmembrane serine protease. Cell Mol Life Sci 61:2866-2877
48. Cunningham BC, Wells JA (1989) Highresolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science 244:1081-1085
49. Ueda T et al (2003) Functional interaction between T2R taste receptors and G-protein alpha subunits expressed in taste receptor cells. J Neurosci 23:7376-7380
50. Di Virgilio F, Steinberg TH, Silverstein SC (1990) Inhibition of Fura-2 sequestration and secretion with organic anion transport blockers. Cell Calcium 11:57-62
51. Bufe B et al (2002) The human TAS2R16 receptor mediates bitter taste in response to beta-glucopyranosides. Nat Genet 32:397-401
52. Behrens M et al (2004) The human taste receptor hTAS2R14 responds to a variety of different bitter compounds. Biochem Biophys Res Commun 319:479-485
53. Kuhn C et al (2004) Bitter taste receptors for saccharin and acesulfame K. J Neurosci 24:10260-10265
54. Sela I et al (2010) G protein coupled receptorsin silico drug discovery and design. Curr Top Med Chem 10:638-656
55. Brockhoff A et al (2007) Broad tuning of the human bitter taste receptor hTAS2R46 to various sesquiterpene lactones, clerodane and labdane diterpenoids, strychnine, and denatonium. J Agric Food Chem 55:6236-6243
56. de Graaf C et al (2008) Molecular modeling of the second extracellular loop of G-protein coupled receptors and its implication on structurebased virtual screening. Proteins 71:599-620
57. Shi L, Javitch JA (2004) The second extracellular loop of the dopamine D2 receptor lines the binding-site crevice. Proc Natl Acad Sci U S A 101:440-445
58. MustafiD, Palczewski K (2009) Topology of class A G protein-coupled receptors: insights gained from crystal structures of rhodopsins, adrenergic and adenosine receptors. Mol Pharmacol 75:1-12
59. Bokoch MP et al (2010) Ligand-specific regulation of the extracellular surface of a G-proteincoupled receptor. Nature 463:108-112
60. Ahuja S et al (2009) Helix movement is coupled to displacement of the second extracellular loop in rhodopsin activation. Nat Struct Mol Biol 16:168-175
61. Shi L, Javitch JA (2002) The binding site of aminergic G protein-coupled receptors: the transmembrane segments and second extracellular loop. Annu Rev Pharmacol Toxicol 42:437-467
62. Coetsee M et al (2008) Identification of Tyr(290(6.58)) of the human gonadotropinreleasing hormone (GnRH) receptor as a contact residue for both GnRH I and GnRH II: importance for high-affinity binding and receptor activation. Biochemistry 47:10305-10313
63. Pronin AN et al (2004) Identification of ligands for two human bitter T2R receptors. Chem Senses 29:583-593
64. Sakurai T et al (2010) Characterization of the beta-D-glucopyranoside binding site of the human bitter taste receptor hTAS2R16. J Biol Chem 285(36):28373-28378
65. Hall SE et al (2009) Elucidation of binding sites of dual antagonists in the human chemokine receptors CCR2 and CCR5. Mol Pharmacol 75:1325-1336
66. Wacker D et al (2010) Conserved binding mode of human beta2 adrenergic receptor inverse agonists and antagonist revealed by X-ray crystallography. J Am Chem Soc 132:11443-11445
67. Jaakola V-P et al (2008) The 2.6 Angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist. Science 322:1211-1217
68. Goodwin JA et al (2007) Roof and floor of the muscarinic binding pocket: variations in the binding modes of orthosteric ligands. Mol Pharmacol 72:1484-1496
69. Rodriguez GJ et al (2010) Evolution-guided discovery and recoding of allosteric pathway specificity determinants in psychoactive bioamine receptors. Proc Natl Acad Sci U S A 107:7787-7792
70. Gloriam DE et al (2009) Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design. J Med Chem 52:4429-4442
71. Wu B et al (2010) Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists. Science 330: 1066-1071
72. Warne T et al (2011) The structural basis for agonist and partial agonist action on a beta(1)-adrenergic receptor. Nature 469:241-244
73. Chien EY et al (2010) Structure of the human dopamine D3 receptor in complex with a D2/ D3 selective antagonist. Science 330:1091-1095
74. Jaakola VP et al (2010) Ligand binding and subtype selectivity of the human A(2A) adenosine receptor: identification and characterization of essential amino acid residues. J Biol Chem 285:13032-13044
75. Hofmann KP et al (2009) A G protein-coupled receptor at work: the rhodopsin model. Trends Biochem Sci 34:540-552
76. de Graaf C, Rognan D (2008) Selective structure-based virtual screening for full and partial agonists of the beta2 adrenergic receptor. J Med Chem 51:4978-4985
77. Vaidehi N (2010) Dynamics and flexibility of G-protein-coupled receptor conformations and their relevance to drug design. Drug Discov Today 15(21-22):951-957
78. Bhattacharya S, Vaidehi N (2010) Computational mapping of the conformational transitions in agonist selective pathways of a G-protein coupled receptor. J Am Chem Soc 132: 5205-5214
79. Provasi D, Filizola M (2010) Putative active states of a prototypic g-protein-coupled receptor from biased molecular dynamics. Biophys J 98:2347-2355
80. Ishikawa M et al (2010) Investigation of the histamine H3 receptor binding site. Design and synthesis of hybrid agonists with a lipophilic side chain. J Med Chem 53:6445-6456
81. Shapiro DA et al (2002) Evidence for a model of agonist-induced activation of 5-hydroxytryptamine 2A serotonin receptors that involves the disruption of a strong ionic interaction between helices 3 and 6. J Biol Chem 277:11441-11449
82. Jiang Q et al (1997) Mutagenesis reveals structure-activity parallels between human A2A adenosine receptors and biogenic amine G protein-coupled receptors. J Med Chem 40: 2588-2595
83. Kim J et al (1995) Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptor. J Biol Chem 270:13987-13997
84. Balaraman GS, Bhattacharya S, Vaidehi N (2010) Structural insights into conformational stability of wild-type and mutant beta1-adrenergic receptor. Biophys J 99:568-577
85. Hilser VJ (2010) An ensemble view of allostery. Science 327:653-654
86. Michino M et al (2009) Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008. Nat Rev Drug Discov 8:455-463
87. Kufareva I et al (2011) Status of GPCR modeling and docking as re flected by communitywide GPCR dock 2010 Assessment, Structure 19:1108-1126
88. Jacobson KA and Costanzi S (2012) New insights for drug design from the X-ray crystallographic structures of GPCRs. Mol Pharmacol doi:10.1124/mol.112. 079335 Forschungsgemeinschaft Forschungsgemeinschaft